Dr. O'Donnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4501 X St
Sacramento, CA 95817Phone+1 916-734-3772Fax+1 916-734-7946- Is this information wrong?
Education & Training
- University of California Davis HealthFellowship, Hematology and Medical Oncology, 1990 - 1993
- University of California Davis HealthResidency, Internal Medicine, 1987 - 1990
- Loyola University Chicago Stritch School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 5 citationsNovel mTORC1 Inhibitors Kill Glioblastoma Stem Cells.Jose Sandoval, Alexey Tomilov, Sandipan Datta, Sonia A. Allen, Robert T. O'Donnell, Thomas K. Sears, Kevin D. Woolard, Dmytro Kovalskyy, James M. Angelastro, Gino A Co...> ;Pharmaceuticals. 2020 Nov 24
- 10 citationsA phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemiaBenjamin Tomlinson, Joseph Tuscano, Mehrdad Abedi, Jeanna L Welborn, Mili Arora, Robert T. O'Donnell, Theodore Wun, Brian A. Jonas> ;American Journal of Hematology. 2019 Nov 1
- 11 citationsA phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma.Anthony B. El-Khoueiry, Robert T. O'Donnell, Thomas J. Semrad, Philip C. Mack, Suzette Blanchard, Nathan Bahary, Yixing Jiang, Yun Yen, John J. Wright, Helen X. Chen, ...> ;Cancer Chemotherapy and Pharmacology. 2018 Mar 8
- Join now to see all
Grant Support
- Immunoliposomal Therapy Of Non-Hodgkin'S LymphomaVeterans Affairs2012
- Phasei/Ii Clinical Trial Of Hhb22.7 Anti-Cd22 Monoclonal Antibody For LymphomaNational Cancer Institute2006–2007
- Combined Modality Radioimmunotherapy For Nonhodgkins LymphomaNational Cancer Institute1999–2002
Hospital Affiliations
- Sacramento Veterans Affairs Medical CenterMather, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: